Grandfield & Dodd LLC increased its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 226,388 shares of the company’s stock after buying an additional 288 shares during the period. Dentsply International accounts for about 2.0% of Grandfield & Dodd LLC’s holdings, making the stock its 15th largest position. Grandfield & Dodd LLC’s holdings in Dentsply International were worth $14,045,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. BlackRock Group LTD increased its stake in shares of Dentsply International by 62.7% in the first quarter. BlackRock Group LTD now owns 1,706,657 shares of the company’s stock valued at $105,182,000 after buying an additional 658,008 shares during the last quarter. BlackRock Inc. increased its stake in shares of Dentsply International by 14.1% in the first quarter. BlackRock Inc. now owns 420,856 shares of the company’s stock valued at $25,936,000 after buying an additional 51,877 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Dentsply International by 0.6% in the first quarter. Franklin Resources Inc. now owns 2,437,080 shares of the company’s stock valued at $150,197,000 after buying an additional 13,914 shares during the last quarter. RMB Capital Management LLC acquired a new stake in shares of Dentsply International during the first quarter valued at $2,181,000. Finally, Prudential Financial Inc. increased its stake in shares of Dentsply International by 20.0% in the first quarter. Prudential Financial Inc. now owns 292,495 shares of the company’s stock valued at $18,027,000 after buying an additional 48,668 shares during the last quarter. 94.58% of the stock is owned by institutional investors and hedge funds.
Dentsply International Inc. (NASDAQ:XRAY) traded down 0.74% during mid-day trading on Monday, hitting $58.99. The stock had a trading volume of 1,427,536 shares. The firm has a 50-day moving average of $60.27 and a 200-day moving average of $61.45. Dentsply International Inc. has a 52-week low of $51.28 and a 52-week high of $65.83.
Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The firm’s quarterly revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 earnings per share. Equities analysts predict that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The company also recently announced a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date is Wednesday, September 28th. Dentsply International’s payout ratio is 14.49%.
Several equities research analysts have recently weighed in on the company. Piper Jaffray Cos. assumed coverage on Dentsply International in a report on Monday, June 13th. They issued an “overweight” rating and a $70.00 price target on the stock. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Bank of America Corp. assumed coverage on Dentsply International in a report on Monday, September 12th. They issued a “buy” rating and a $70.00 price target on the stock. Barrington Research downgraded Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Finally, Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Dentsply International has a consensus rating of “Buy” and an average price target of $66.82.
In other Dentsply International news, SVP Maureen J. Macinnis sold 17,650 shares of the business’s stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $60.61, for a total value of $1,069,766.50. Following the sale, the senior vice president now owns 19,630 shares of the company’s stock, valued at $1,189,774.30. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Rainer Berthan sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the sale, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.